Literature DB >> 8154496

Idiopathic focal segmental glomerulosclerosis in a patient with systemic lupus erythematosus: an unusual combination.

P L Hickman1, K D Nolph, R Jacobs, A M Luger, S E Walker.   

Abstract

Renal involvement is a major cause of morbidity in patients with systemic lupus erythematosus (SLE). Histologic examination of renal tissue using light microscopy, immunofluorescent staining, and electron microscopy permit identification of glomerular immune complex deposits in virtually all patients with SLE. We report a patient who fulfilled four American College of Rheumatology criteria for the classification of SLE whose clinical course was consistent with SLE, yet whose renal failure resulted from focal glomerulosclerosis that was not mediated by immune complexes. The characteristics of this case of focal glomerulosclerosis that differentiate it from healed focal proliferative glomerulonephritis are discussed.

Entities:  

Mesh:

Year:  1994        PMID: 8154496     DOI: 10.1016/s0272-6386(12)80382-9

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  4 in total

Review 1.  Lupus podocytopathy: a distinct entity of lupus nephritis.

Authors:  Duqun Chen; Weixin Hu
Journal:  J Nephrol       Date:  2017-12-22       Impact factor: 3.902

2.  Clinical-Morphological Features and Outcomes of Lupus Podocytopathy.

Authors:  Weixin Hu; Yinghua Chen; Shaofan Wang; Hao Chen; Zhengzhao Liu; Caihong Zeng; Haitao Zhang; Zhihong Liu
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-16       Impact factor: 8.237

Review 3.  Podocyte Injury in Lupus Nephritis.

Authors:  Hamza Sakhi; Anissa Moktefi; Khedidja Bouachi; Vincent Audard; Carole Hénique; Philippe Remy; Mario Ollero; Khalil El Karoui
Journal:  J Clin Med       Date:  2019-08-29       Impact factor: 4.241

4.  Lupus podocytopathy superimposed on diabetic glomerulosclerosis: A case report.

Authors:  Lin Liu; Brian Murray; John E Tomaszewski
Journal:  Medicine (Baltimore)       Date:  2021-09-17       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.